Cellyan Biotechnology (HKPD)

• Market cap: $7.04M
• 1 day: 1.85%
• 5 days: 3.11%
• 1 month: -22.32%
• 3 months: -20%
• 6 months: -53.96%
• Year to date: -20.67%
• 1 year: -46.67%
• 5 years: -77.3%
• 10 years: -77.3%
• Sector: Healthcare
• Industry: Pharmaceutical Retailers

About: Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Employees: 27